Patrick Ott News Today

But in the bahamas where dorian hit last weekend, only to stall and dump heavy, heavy rain and high winds for three days in a row, shellshocked residents are struggling to make sense of what happened during the strongest storm to ever hit the island nation. Words cant describe it. I dont twish on nobody. Nobody [ sobbing ] they could never categorize this, never. It was like an atomic bomb went off. Bahamas Prime Minister tells cnn that the official death toll from Hurricane Dorian now stands at...

Patrick Ott, MD, PhD, discusses the investigation of cancer vaccines, highlighting the clinical implications of this treatment modality in melanoma.

After years of lackluster results, cancer vaccines seem poised for success. Finally.

Personalized cancer vaccines are on the horizon and could be available for some patient populations as soon as next year, one expert said.

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript November 17, 2023 Operator: Good morning. My name is Alan, and I will be your operator today. At this time I would like to welcome you to Imunon’s Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] I would like now to turn the call over to […]

From Alzheimer’s discoveries to animal organ transplants, new technological breakthroughs are improving and extending lives.

Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE, N.J., Sept. 13, 2023 (GLOBE...

Researchers believe personalised medicine and vaccines are probably the next big thing in the quest to reduce cancer deaths

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.

The next big advance in cancer treatment could be a vaccine that can shrink tumors and stop cancer from coming back. Among the targets for the experimental shots: melanoma, pancreatic cancer, breast cancer and lung cancer. The research has reached a turning point, scientists say, with many predicting new cancer vaccine approvals within five years. These are vaccines to treat existing disease but preventing cancer before it starts is another line of vaccine research.